Trending Topics
Zoll header_$.png

Nationwide, communities continue to battle the effects of the opioid crisis. Litigation brought by states against drug distributors, manufacturers and pharmacy chains has produced opioid settlement funding designed to bring relief to communities affected by the epidemic. The various funding mechanisms (how to request, how to apply and to who) is evolving and varies by state.

First responders are on the front line of this crisis treating overdose patients, securing illegal, dangerous drugs and managing the various scenarios related to opioid calls. For public safety agencies, including EMS, opioid settlement funding may be tapped for a variety of purposes. For this reason, public safety leaders must understand the basics of the settlements, how funds will be distributed and how your agency may be able to tap into funding in a responsible manner.

Follow our Opioid Settlement Funding: Compensation For Communities coverage, brought to you by ZOLL Medical, to stay informed.

SPONSORED BY
Related news about the opioid crisis and improving patient outcomes
Honolulu EMS warns personnel to be on the lookout for signs of xylazine
When Russ Winters was found unresponsive, his wife began doing chest compressions, then his daughter took over until paramedics arrived
A Vanderbilt University Medical Center study compared intubation attempts in over 1,400 patients in hospitals across the nation
Matthew W. Milburn told first responders the unconscious subject was ’10-4' and they could cancel their response
Hennepin EMS collaborated with addiction medicine experts to establish a treatment protocol
40 rescuers in Cheshire County were recognized for their work in saving victims of sudden cardiac arrest
Xylazine, often mixed with fentanyl, has necrotizing effects that rot the skin and lead to amputations
Knowing how xylazine presents clinically, as well as how it impacts overdose management is important for any provider responding to illicit drug overdoses
Albuterol, fentanyl and naloxone injectable are among the drugs being recalled – many of which are in very short supply, with no alternate source available
About the Sponsor: ZOLL
ZOLL is a resuscitation solutions pioneer, distinguished by consistency in management, ownership, and approach for nearly 30 years. As a financially strong, public company, ZOLL has an enviable product quality and reliability record. ZOLL technologies to help advance the practice of resuscitation include pacing, defibrillation, circulation, ventilation, data management, and fluid resuscitation.

These comprehensive technologies help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest and trauma victims. ZOLL’s commitment is to be the dependable choice for all providers in the field of resuscitation.

ZOLL markets and sells its products, including AED Plus®, AED Pro®, the R Series™ defibrillator, the AutoPulse® non-invasive cardiac support pump, and the LifeVest® wearable defibrillator in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and Australia.